Publicacións nas que colabora con Clara Bueno Uroz (17)

2019

  1. Enhanced hemato-endothelial specification during human embryonic differentiation through developmental cooperation between AF4-MLL and MLL-AF4 fusions

    Haematologica, Vol. 104, Núm. 6, pp. 1189-1201

2018

  1. Correction to: NG2 antigen is involved in leukemia invasiveness and central nervous system infiltration in MLL-rearranged infant B-ALL (Leukemia, (2018), 32, 3, (633-644), 10.1038/leu.2017.294)

    Leukemia

  2. NG2 antigen is involved in leukemia invasiveness and central nervous system infiltration in MLL-rearranged infant B-ALL

    Leukemia, Vol. 32, Núm. 3, pp. 633-644

2017

  1. RUNX1c Regulates Hematopoietic Differentiation of Human Pluripotent Stem Cells Possibly in Cooperation with Proinflammatory Signaling

    Stem Cells, Vol. 35, Núm. 11, pp. 2253-2266

2015

  1. SCL/TAL1-mediated transcriptional network enhances megakaryocytic specification of human embryonic stem cells

    Molecular Therapy, Vol. 23, Núm. 1, pp. 158-170

  2. The Notch ligand DLL4 specifically marks human hematoendothelial progenitors and regulates their hematopoietic fate

    Leukemia, Vol. 29, Núm. 8, pp. 1741-1753

2014

  1. HOXA9 promotes hematopoietic commitment of human embryonic stem cells

    Blood, Vol. 124, Núm. 20, pp. 3065-3075

  2. Ligand-independent FLT3 activation does not cooperate with MLL-AF4 to immortalize/transform cord blood CD34+ cells

    Leukemia, Vol. 28, Núm. 3, pp. 666-674

2013

  1. FLT3 activation cooperates with MLL-AF4 fusion protein to abrogate the hematopoietic specification of human ESCs

    Blood, Vol. 121, Núm. 19, pp. 3867-3878

  2. The role of RUNX1 isoforms in hematopoietic commitment of human pluripotent stem cells

    Blood

2012

  1. A human ESC model for MLL-AF4 leukemic fusion gene reveals an impaired early hematopoietic-endothelial specification

    Cell Research, Vol. 22, Núm. 6, pp. 986-1002

  2. Maintenance of human embryonic stem cells in media conditioned by human mesenchymal stem cells obviates the requirement of exogenous basic fibroblast growth factor supplementation

    Tissue Engineering - Part C: Methods, Vol. 18, Núm. 5, pp. 387-396

  3. Maintenance of human embryonic stem cells in mesenchymal stem cell-conditioned media augments hematopoietic specification

    Stem Cells and Development, Vol. 21, Núm. 9, pp. 1549-1558

  4. Residual expression of the reprogramming factors prevents differentiation of iPSC generated from human fibroblasts and cord blood CD34+ progenitors

    PLoS ONE, Vol. 7, Núm. 4

  5. SCL/TAL1 regulates hematopoietic specification from human embryonic stem cells

    Molecular Therapy

  6. Specific marking of hESCs-derived hematopoietic lineage by WAS-promoter driven lentiviral vectors

    PLoS ONE, Vol. 7, Núm. 6

2011

  1. Enforced expression of MLL-AF4 fusion in cord blood CD34+ cells enhances the hematopoietic repopulating cell function and clonogenic potential but is not sufficient to initiate leukemia

    Blood, Vol. 117, Núm. 18, pp. 4746-4758